Leaflet IPRAXA 500mcg / 2ml solution for inhalation by nebuliser
Indicated for: nasal congestion; rhinitis
Route of administration: inhalation
Substance: ipratropium bromide (antimuscarinic bronchodilator)
ATC: R03BB01 (Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics)
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
Older people may have an increased risk of side effects.
Ipratropium bromide is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD) and bronchial asthma. It works by blocking muscarinic receptors, relaxing airway muscles, and improving breathing.
The medication is administered as an aerosol or nebulizer solution, as directed by a doctor. It is important to follow the recommended dose to avoid side effects.
Side effects may include dry mouth, cough, throat irritation, or dizziness. In rare cases, severe allergic reactions or breathing difficulties may occur.
Ipratropium bromide is not recommended for patients with hypersensitivity to this medication or other anticholinergics.
General data about IPRAXA 500mcg / 2ml
- Substance: ipratropium bromide
- Date of latest medicines list: 01-01-2015
- Product code: W52856001
- Concentration: 500mcg / 2ml
- Pharmaceutical form: solution for inhalation by nebuliser
- Quantity: 20
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for ipratropium bromide
Concentrations available for ipratropium bromide
- 20mcg/dose
- 250mcg/2ml
- 250mcg/ml
- 500mcg/2ml